COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04338009


Column Value
Trial registration number NCT04338009
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Jordana B. Cohen

Contact
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Not reported

Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-04-08

Recruitment status
Last imported at : April 11, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

inclusion criteria: age 18 years or older hospitalization with a suspected diagnosis of covid-19, based on: (a) a compatible clinical presentation with a positive laboratory test for sars-cov-2, or (b) considered by the primary team to be a person under investigation due to undergo testing for covid-19 in addition to compatible pulmonary infiltrates on chest x-ray (mutilobar, intersticial or ground glass opacities). use of acei or arb as an outpatient prior to hospital admission.

Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

systolic blood pressure <100 mmhg. systolic blood pressure > 180 mmhg or >160 if unable to substitute aceis/arbs for another antihypertensive class, per the investigator's discretion. diastolic blood pressure > 110 mmhg known history of heart failure with reduced ejection fraction (ef <40%) on their most recent echo and/or clinical heart failure with unknown ef (i.e. no echo in approximately the past year). serum k>5.0 meq/l on admission. known pregnancy or breastfeeding. egfr <30 ml/min/1.73m2 >50% increase in creatinine (to a creatinine >1.5 mg/dl) compared to most recent creatinine in the past six months, if available urine protein-to-creatitine ratio > 3 g/g or proteinuria > 3 g/24-hours within the past year ongoing treatment with aliskiren or sacubitril-valsartan. inability to obtain informed consent from patient. inability to read and write or lack of access to a smart phone, computer or tablet device at the time of evaluation.

Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Dec. 4, 2022, 8 p.m.
Source : ClinicalTrials.gov

University of Pennsylvania

Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

United States

Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Moderate/severe/critical disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

5: Moderate/severe/critical disease at enrollment

Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

152

primary outcome
Last imported at : Dec. 4, 2022, 8 p.m.
Source : ClinicalTrials.gov

Hierarchical Composite Endpoint

Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "Participants received intervention already before enrollment. Treatment was continued and discontinued.", "treatment_id": 1410, "treatment_name": "Ace inhibitor+angiotensin receptor blocker (arb)", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]